TELA
TELA Bio, Inc.Company Information
- Company Name
- TELA Bio, Inc.
- CIK
- CIK0001561921
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- TELA: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- TELA
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-09-17
- Last sale
- 2024-07-02
- Shares purchased (TTM)
- 3,706,500
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 25,747,187
- Shares outstanding
- 57,414,360
- Ownership
- 44.84%
Earnings Market Reaction
- Filing date
- 2026-08-11
- Price on filing date
- —
- 1-month reaction
- 4.05%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 30 | 40 | 51 | 30 | 35 | 43 | 53 | 17 | 26 | 37 | 47 | 58 | ||||||
| Receivables Net Current | 10 | 10 | 10 | 11 | 11 | 11 | 10 | 11 | 9 | 10 | 10 | 8 | ||||||
| Inventory Net | 11 | 12 | 11 | 12 | 11 | 14 | 13 | 14 | 13 | 14 | 13 | 14 | ||||||
| Prepaid Expense And Other Assets Current | 3 | 3 | 3 | 4 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | ||||||
| Assets Current | 54 | 64 | 76 | 56 | 61 | 70 | 78 | 44 | 51 | 63 | 72 | 82 | ||||||
| Property Plant And Equipment Net | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Intangible Assets Net Excluding Goodwill | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | ||||||
| Deferred Income Tax Assets Net | - | - | - | 0 | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Other Assets Noncurrent | 0 | 0 | 1 | - | 1 | 2 | 2 | 3 | 3 | 3 | - | - | ||||||
| Restricted Cash Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Assets | 60 | 70 | 81 | 62 | 68 | 77 | 87 | 53 | 60 | 72 | 78 | 87 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 3 | 4 | 2 | 2 | 2 | 4 | 2 | 2 | 2 | 3 | 2 | 3 | ||||||
| Accrued Liabilities Current | 15 | 14 | 16 | 15 | 14 | 13 | 13 | 14 | 13 | 12 | 15 | 12 | ||||||
| Long Term Debt Current | - | - | - | - | 3 | - | - | - | - | - | - | - | ||||||
| Liabilities Current | 18 | 18 | 18 | 17 | 19 | 17 | 16 | 17 | 15 | 15 | 17 | 15 | ||||||
| Long Term Debt Noncurrent | 56 | 56 | 56 | 41 | 38 | 41 | 41 | 41 | 41 | 41 | 41 | 40 | ||||||
| Other Liabilities Noncurrent | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | ||||||
| Liabilities | 76 | 75 | 75 | 60 | 58 | 59 | 58 | 59 | 57 | 57 | 59 | 57 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 405 | 405 | 404 | 390 | 389 | 388 | 387 | 343 | 342 | 341 | 340 | 338 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Retained Earnings Accumulated Deficit | -421 | -410 | -398 | -389 | -380 | -370 | -359 | -350 | -339 | -327 | -321 | -308 | ||||||
| Stockholders Equity | -16 | -5 | 6 | 2 | 9 | 18 | 28 | -6 | 3 | 14 | 19 | 31 | ||||||
| Liabilities And Stockholders Equity | 60 | 70 | 81 | 62 | 68 | 77 | 87 | 53 | 60 | 72 | 78 | 87 | ||||||
| Allowance For Doubtful Accounts Receivable Current | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | ||||||
| Common Stock Shares Issued | 45 | 45 | 45 | 40 | 40 | 40 | 39 | 25 | 25 | 25 | 24 | 24 | ||||||
| Shares Outstanding | 45 | 45 | 45 | 40 | 40 | 40 | 39 | 25 | 25 | 25 | 24 | 24 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialTELA Bio, Inc. (TELA) — SEC Financial Statements & Analysis
TELA Bio, Inc. (TELA) is a surgical & medical instruments & apparatus company, incorporated in DE. TELA Bio, Inc. trades on Nasdaq as: TELA. TELA Bio, Inc. (TELA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11. Based on that filing, TELA Bio, Inc. carries a market cap of $43.06M, a P/E ratio of -1.05x, a P/B ratio of -2.71x, a P/S ratio of 0.54x, an enterprise value of $68.52M, and an EV/EBITDA multiple of -2.08x. On profitability, it posts a gross margin of 67.81%, an operating margin of -41.92%, a net margin of -51.53%, a Return on Equity (ROE) of 1232.54%, a Return on Assets (ROA) of -64.71%, and a Return on Invested Capital (ROIC) of -237.05%. Per share, it reports EPS of $-0.72, diluted EPS of $-0.72, free cash flow per share of $-0.55, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 6.09% year-over-year, net income growth of 1.01% year-over-year, and EPS growth of -20.19% year-over-year. On the balance sheet, it maintains a current ratio of 2.99x, a quick ratio of 2.20x, working capital of $36.27M, a debt-to-equity ratio of -4.77x, a debt ratio of 1.27, an interest coverage ratio of -4.81x, free cash flow of $-31.62M (TTM), and net debt of $25.46M. Figures sourced from SEC EDGAR.
- Market Cap
- $43.06M
- P/E TTM
- -1.05x
- EPS TTM
- $-0.72
- P/B TTM
- -2.71x
- ROE TTM
- 1232.54%
- ROA TTM
- -64.71%
- Debt To Equity
- -4.77x
- Free Cash Flow TTM
- $-31.62M
- Net Revenue TTM Growth 1Y
- 6.09%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is TELA Bio, Inc. in?
TELA Bio, Inc. (TELA) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does TELA trade on?
TELA Bio, Inc. (TELA) trades on the Nasdaq.
Where is TELA Bio, Inc. incorporated?
TELA Bio, Inc. is incorporated in DE.
When was TELA Bio, Inc. (TELA)'s most recent SEC filing?
TELA Bio, Inc. (TELA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11.
What is TELA's market cap?
TELA Bio, Inc. (TELA) has a market capitalization of $43.06M as of 2026-06-30.
What is TELA's EPS (earnings per share)?
TELA Bio, Inc. (TELA)'s trailing twelve month EPS is $-0.72 as of 2026-06-30.
What is TELA's ROE (return on equity)?
TELA Bio, Inc. (TELA)'s trailing twelve month Return on Equity (ROE) is 1232.54% as of 2026-06-30.
What is TELA's ROA (return on assets)?
TELA Bio, Inc. (TELA)'s trailing twelve month Return on Assets (ROA) is -64.71% as of 2026-06-30.
What is TELA's ROIC (return on invested capital)?
TELA Bio, Inc. (TELA)'s trailing twelve month Return on Invested Capital (ROIC) is -237.05% as of 2026-06-30.
What is TELA's EV/EBITDA?
TELA Bio, Inc. (TELA)'s trailing twelve month EV/EBITDA is -2.08x as of 2026-06-30.